JCU CORPORATION
4975・Prime Market・Chemicals
JCU CORPORATION4975
JCU CORPORATION4975
Reference Indicators
Market Cap
1,662¥100M
P/E (Forecast)
—
P/B
2.9x
Dividend Yield (Forecast)
2.84%
ROE
17.7%
EV/EBITDA
10.8x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 24,256 | 24,859 | 24,859 | 28,356 | 29,672 |
Cost of Sales | 8,526 | 9,675 | 9,675 | 9,754 | 9,062 |
Gross Profit | 15,729 | 15,184 | 15,184 | 18,602 | 20,610 |
SG&A Expenses | 6,738 | 7,143 | 7,143 | 8,088 | 8,454 |
Operating Income | 8,990 | 8,041 | 8,041 | 10,513 | 12,156 |
Non-operating Income | 403 | 323 | 323 | 480 | 355 |
Non-operating Expenses | 162 | 148 | 148 | 74 | 64 |
Ordinary Income | 9,231 | 8,216 | 8,216 | 10,920 | 12,447 |
Extraordinary Income | 1 | 2 | 2 | 45 | 171 |
Extraordinary Losses | 27 | 194 | 194 | 3 | 49 |
Pre-tax Income | 9,205 | 8,024 | 8,024 | 10,962 | 12,569 |
Income Taxes | 2,835 | 2,493 | 2,493 | 3,464 | 3,494 |
Net Income | 6,370 | 5,530 | 5,530 | 7,497 | 9,074 |
EBITDA | 9,610 | 8,768 | 8,768 | 11,379 | 13,168 |
Gross Margin | 64.8% | 61.1% | 61.1% | 65.6% | 69.5% |
Operating Margin | 37.1% | 32.3% | 32.3% | 37.1% | 41.0% |
ROA | 15.6% | 11.1% | 11.1% | 13.7% | 14.5% |
ROE | 20.9% | 14.8% | 13.8% | 16.7% | 17.7% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| 薬品事業 | 26,926 | 12,716 | 47.2% |
| 装置事業 | 2,746 | 413 | 15.0% |